Hyloris Pharmaceuticals SA (EBR:HYL)
Belgium
· Delayed Price · Currency is EUR 5.28
+0.02 (0.38%)
Feb 21, 2025, 5:02 PM CET
Hyloris Pharmaceuticals Market Cap
Hyloris Pharmaceuticals has a market cap or net worth of €147.84 million as of February 21, 2025. Its market cap has decreased by -59.07% in one year.
Market Cap
147.84M
Enterprise Value
121.77M
Revenue
6.94M
Ranking
n/a
PE Ratio
n/a
Stock Price
€5.28
Market Cap Chart
Since June 29, 2020, Hyloris Pharmaceuticals's market cap has decreased from 244.70M to 147.84M, a decrease of -39.58%. That is a compound annual growth rate of -10.27%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 20, 2025 | 147.28M | -19.57% |
| Dec 31, 2024 | 183.12M | -48.71% |
| Dec 29, 2023 | 357.00M | 14.84% |
| Dec 30, 2022 | 310.88M | -30.44% |
| Dec 31, 2021 | 446.90M | 82.11% |
| Dec 31, 2020 | 245.41M | 0.29% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| argenx SE | 37.62B |
| UCB SA | 34.49B |
| Financière de Tubize | 6.38B |
| Fagron NV | 1.41B |
| Ion Beam Applications | 407.37M |
| Nyxoah | 374.27M |
| Onward Medical | 257.95M |
| Sequana Medical NV | 83.08M |